EUCTR2011-004791-11-GB进行中（未招募）1 期
Efficacy and safety of CD5024 1% cream versus metronidazole 0.75% cream in subjects with papulopustular rosacea over 16 weeks treatment, followed by a 36-week extension period
Galderma R&D SNC0 个研究点目标入组 962 人开始时间: 2012年1月17日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 962
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Male or female subjects 18 years of age or older at the Screening Visit,
- •- Subjects with papulopustular rosacea scored 3 (moderate) or 4 (severe) according to the Investigator Global Assessment (IGA) at Screening and Baseline visits,
- •- Subjects with at least 15 but not more than 70 inflammatory lesions (papules and pustules) on the face at Screening and Baseline visits.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 380
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 580
排除标准
- •- Subjects with particular forms of rosacea (rosacea conglobata, rosacea fulminans, isolated pustulosis of the chin) or other facial dermatoses that may be confounded with papulopustular rosacea, such as peri oral dermatitis, facial keratosis pilaris, or seborrheic dermatitis and acne at Screening and Baseline visits,
- •- Subjects with rosacea with more than two nodules on the face at Screening and Baseline visits.
研究者
相似试验
进行中（未招募）
不适用
CD5024 1% cream versus metronidazole 0.75% cream in papulopustular rosacea (PPR) studyEUCTR2011-004791-11-CZGalderma R&D SNC960
进行中（未招募）
不适用
CD5024 1% cream versus metronidazole 0.75% cream in papulopustular rosacea (PPR) studyPapulo Pustular RosaceaMedDRA version: 16.1Level: PTClassification code 10039218Term: RosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-004791-11-DEGalderma R&D SNC960
进行中（未招募）
不适用
CD5024 1% cream versus metronidazole 0.75% cream in papulopustular rosacea (PPR) studyPapulo Pustular RosaceaMedDRA version: 14.1Level: PTClassification code 10039218Term: RosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-004791-11-HUGalderma R&D SNC960
进行中（未招募）
不适用
CD5024 1% cream versus metronidazole 0.75% cream in papulopustular rosacea (PPR) studyPapulo Pustular RosaceaMedDRA version: 14.1Level: PTClassification code 10039218Term: RosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-004791-11-BGGalderma R&D SNC960
已完成
3 期
CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) StudyPapulopustular RosaceaNCT01493947Galderma R&D962